Quarterly report pursuant to Section 13 or 15(d)

Abeona Therapeutics LLC Acquisition (Details)

v3.2.0.727
Abeona Therapeutics LLC Acquisition (Details)
 6 Months Ended
May. 15, 2015
USD ($)
Milestone
$ / shares
shares
Jun. 30, 2015
USD ($)
Jun. 30, 2014
USD ($)
Dec. 31, 2014
USD ($)
Business Combination, Consideration Transferred [Abstract]        
Initial consideration   $ 31,758,000 $ 0  
Allocation of the purchase price        
Goodwill   38,955,000   $ 0
Contingent consideration liability   $ (6,489,000)   $ 0
Abeona Therapeutics LLC [Member]        
Business Acquisition [Line Items]        
Stock issued in acquisition (in shares) | shares 3,979,761      
Business acquisition, share price (in dollars per shares) | $ / shares $ 7.98      
Number of shares issued to company (in shares) | shares (3,979,761)      
Number of milestones | Milestone 3      
Business Combination, Consideration Transferred [Abstract]        
Initial consideration $ 31,758,000      
Contingent consideration 6,489,000      
Total purchase price 38,247,000      
Allocation of the purchase price        
Cash 3,697,000      
Accounts receivable 1,000      
Prepaid expenses 28,000      
Property and equipment 51,000      
Other assets 1,000      
Accounts payable (153,000)      
Total tangible assets 3,625,000      
Licensing agreement 2,156,000      
Goodwill 38,955,000      
Contingent consideration liability (6,489,000)      
Total net asset value 38,247,000      
Acquisition transaction cost $ 375,000